Insights

Professional
Practice
Industry
Region
Trending Topics
Location
Type

Sort by:

Firm News 22 results

Firm News | 1 min read | 06.30.25

DataBahn.ai Raises $17M Series A To Advance Security-Native Data Pipelines

DataBahn.ai, a leader in AI-powered, security-native data pipeline platforms for modern enterprises, has secured $17 million in Series A funding led by Forgepoint Capital, with participation from S3 Ventures and GTM Capital. This brings the company’s total funding to $19 million. Crowell represented Forgepoint Capital, a leading venture capital firm that partners with transformative cybersecurity, artificial intelligence and infrastructure software companies protecting the digital future, in the transaction. The investment will accelerate DataBahn.ai’s product roadmap for agentic AI—autonomous agents that automate data engineering tasks—and support global expansion as the company cements its position as a trusted foundation for enterprise data pipelines. Already trusted by Fortune 50 and Global 2000 organizations, DataBahn.ai’s technology has helped customers reduce telemetry processing costs by over 50%, automate most data engineering workloads, and eliminate blind spots across SIEM, observability, and AI pipelines.

Firm News | 1 min read | 06.18.25

Crowell & Moring Represents Conveyor in $20M Series B

Crowell & Moring represented Conveyor, a leader in AI-powered customer trust workflows for security reviews and RFPs, in successfully raising $20 million in Series B funding, bringing total funding to $40 million. This round was led by SignalFire, with participation from Oregon Venture Fund and Cervin Ventures. The investment will fuel Conveyor's expansion in AI research, engineering, and go-to-market initiatives, supporting the development of its AI Agents, Sue and Phil.

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn.
...

Client Alerts 6 results

Client Alert | 6 min read | 07.22.25

The One Big Beautiful Bill Act Expands Favorable QSBS Treatment

On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (the “Act”), after it was passed by Congress on July 3, 2025. Notably, the Act made significant and welcome changes from the perspective of startup company stockholders and venture capital investors to the qualified small business stock (“QSBS”) rules set forth in Internal Revenue Code (“Code”) Section 1202. In a nutshell, the changes modernize (by adjusting for inflation) and expand the already favorable tax treatment for QSBS under Code Section 1202. The Act also permanently reinstates elective expensing for qualifying domestic research and experimental expenditures that will likely help more startups in research and capital intensive sectors qualify for favorable QSBS treatment.
...

Client Alert | 3 min read | 07.05.23

Venture Capital Firms and Non-Traditional Defense Technology Contractors Push for DoD Procurement Reform and Defense Industrial Base Expansion

On June 23, 2023, a coalition of companies, including venture capital firms like Kleiner Perkins, General Catalyst and Founders Fund, and start-up defense technology companies, published an open letter to the Department of Defense (DoD), addressed to Secretary Lloyd J. Austin, petitioning DoD to consider procurement reform to help “overcome barriers to innovation.”  The group asserts these barriers create “antiquated methods for developing requirements and selecting technologies that have drastically limited” DoD’s access to “the best commercial innovation.”  In particular, the coalition endorsed adopting four recommendations pulled from a report by The Atlantic Council, a non-partisan international affairs think tank.
...

Client Alert | 2 min read | 12.08.22

Department of Defense Establishes Office of Strategic Capital to Enhance Investment in National Security Critical Technology

On December 1, 2022, Department of Defense (DoD) Secretary Lloyd J. Austin III announced the establishment of the DoD Office of Strategic Capital (OSC).  The mission statement of the OSC is to build an “enduring technical advantage” for the United States by helping partner contractors with private investment to develop national security critical technologies, including those related to advanced materials, next-generation biotechnology, and quantum science.  OSC will coordinate with existing organizations such as the Defense Advanced Research Projects Agency (DARPA) and the Defense Innovation Unit (DIU), which promotes acceleration of the military use of commercial technologies.
...

Press Coverage 11 results

Publications 2 results

Publication | 01.30.22

Emerging Companies 101: 6 Avoidable Mistakes

GrowthStudio

Events 1 result

Event | 03.18.24, 6:00 PM EDT - 9:00 PM EDT

Payload Space Capitol III

Join Payload at their third Space Capitol event, hosted by Crowell, where we will bring together emerging space companies and the government for a thought leadership and networking experience.

Webinars 1 result

Webinar | 02.25.25, 1:00 PM EST - 2:30 PM EST

First 100 Days: Navigating New Frontiers: Life Sciences in the Trump Era

Please join us for a post-Election webinar with the heads of our Government Affairs group who will address the myriad of areas in the Life Sciences industry that will likely be impacted by the new administration, including FDA, NIH, drug pricing, imports, and exports.